Home
Scholarly Works
Anticoagulants in Venous Thromboembolism
Journal article

Anticoagulants in Venous Thromboembolism

Abstract

Lowering the mortality from venous thromboembolism depends on effective prophylaxis including use of anticoagulants in high-risk patients, and on adequate anticoagulant therapy for established thrombosis. Heparin in low doses given subcutaneously seems effective and safe as prophylaxis in high-risk surgical patients. Heparin is also the drug of choice for managing established venous thromboembolism.

Authors

Hirsh J; Gallus AS

Journal

Postgraduate Medicine, Vol. 55, No. 1, pp. 211–217

Publisher

Taylor & Francis

Publication Date

January 1, 1974

DOI

10.1080/00325481.1974.11713670

ISSN

0032-5481
View published work (Non-McMaster Users)

Contact the Experts team